Telomerase-Specific Replication-Selective Virotherapy for Human Cancer
2004 · Clinical Cancer Research · 258 citations
https://doi.org/10.1158/1078-0432.ccr-1075-3
S
Shunsuke Kagawa
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
569
Papers
7.9K
Citations
51
h-index
158
i10-index
Shunsuke Kagawa is an academic researcher from Osaka City University. The author has contributed to research in topics: Virus-based gene therapy research & Cancer Research and Treatments & RNA Interference and Gene Delivery. The author has an h-index of 51, co-authored 484 publications.
ORCID: 0000-0002-3610-8211Papers by this author
worksTargeting neutrophil extracellular traps with thrombomodulin prevents pancreatic cancer metastasis
2020 · Cancer Letters · 132 citations
https://doi.org/10.1016/j.canlet.2020.10.015
Sarcopenia and Comorbidity in Gastric Cancer Surgery as a Useful Combined Factor to Predict Eventual Death from Other Causes
2018 · Annals of Surgical Oncology · 94 citations
https://doi.org/10.1245/s10434-018-6354-4
Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells
2005 · Experimental Cell Research · 88 citations
https://doi.org/10.1016/j.yexcr.2005.10.026
Enhanced antitumor efficacy of telomerase‐selective oncolytic adenoviral agent OBP‐401 with docetaxel: Preclinical evaluation of chemovirotherapy
2006 · International Journal of Cancer · 73 citations
https://doi.org/10.1002/ijc.21846
Phase I dose-escalation study of endoscopic intratumoral injection of OBP-301 (Telomelysin) with radiotherapy in oesophageal cancer patients unfit for standard treatments
2021 · European Journal of Cancer · 62 citations
https://doi.org/10.1016/j.ejca.2021.04.043
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat